α2β1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1127-1134

  Vo, Hang P ^a   Lee, Matt K ^a   Crowe, David L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chloramphenicol acetyl transferase; Extracellular matrix; Matrix metalloproteinase; Retinoic acid; Squamous cell carcinoma; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE B; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINOIC ACID; ANTINEOPLASTIC AGENT; COLLAGEN RECEPTOR; COLLAGENASE; GELATIN; PROTEIN KINASE (CALCIUM,CALMODULIN); TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ARTICLE; CANCER INVASION; ENZYME ACTIVITY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL CULTURE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COLLAGENASES; DOWN-REGULATION; EXTRACELLULAR MATRIX; GELATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RECEPTORS, COLLAGEN; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031593365     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Liotta L: Tumor invasion and metastases: role of the extracellular matrix. Cancer Res 46: 1-7, 1986.
2. Kohn EC and Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856-1862, 1995.
3. Matrisian LM: The matrix degrading metalloproteinases. BioEssays 14: 455-463, 1992.
4. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991.
5. Werb Z, Tremble PM, Behrendsten O, Crowley E and Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109: 877-889, 1989.
6. Aubel DT and Brinckerhoff CE: The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30: 4629-4635, 1991.
7. Clark EA and Brugge JS: Integrins and signal transduction pathways: the road taken. Science 268: 233-239, 1995.
8. Sudbeck BD, Parks WC, Weigus HG and Pentland AP: Collagen stimulated induction of keratinocyte collagenase is mediated via tyrosine kinase and protein kinase C activities. J Biol Chem 269: 30022-30029, 1994.
9. Helige C, Smolle J, Zelinig G, Hartmann E, Fink-Puches R, Kerl H and Trifthart HA: Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid. Clin Exp Metastasis 11: 409-418, 1993.
10. Xu XC, Zile MH, Lippmann SM, Lee JS, Lee JJ and Hong WK: Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression. Cancer Res 55: 5507-5511, 1995.
11. Hendrix MJC, Wood WR and Seftor EA: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50: 4121-4130, 1990.
12. Pan L, Eckhoff C and Brinckerhoff CE: Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 57: 575-589, 1995.
13. Mangelsdorf DJ, Umesono K and Evans RM: The retinoid receptors. In: The Retinoids. Sporn MB, Roberts AB and Goodman DS (eds). 2nd edition. Raven Press, New York, pp319-350, 1994.
14. Leid M, Kastner P and Chambon P: Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochem Sci 17: 427-433, 1992.
15. Lauricella-Lefebvre MA, Castronovo V, Sato H, Seiki M, French DL and Merville MP: Stimulation of the 92 kDa type IV collagenase promoter and enzyme expression in human melanoma cells. Invasion Metastasis 13: 289-300, 1993.
16. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD and Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993.
17. Crowe DL: Retinoic acid mediates posttranscriptional regulation of keratin 19 mRNA levels. J Cell Sci 106: 183-188, 1993.
18. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269: 31807-31813, 1994.
19. Sato H and Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993.
20. Jiang CK, Connolly D and Blumenberg M: Comparison of methods for transfection of human epidermal keratinocytes. J Invest Derm 97: 969-973, 1991.
21. Pei D and Weiss SJ: Transmembrane deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix degrading activity. J Biol Chem 271: 9135-9140, 1996.
22. Gaetano C, Melchiori A, Albani A, Benelli R, Faicioni R, Modesti A, Modica A, Scarpa S and Sacchi A: Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma line. Clin Exp Metastasis 12: 63-72, 1994.
23. Testa JE: Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, Hep-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Cancer Res 52: 5597-5603, 1992.
24. Wayner EA and Carter WG: Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 105: 1873-1884, 1987.
25. Wayner EA, Carter WG, Piotrowicz RS and Kunicki TJ: The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 107: 1881-1891, 1988.
26. Nakajima M, Lotan D and Baig MM: Inhibition by retinoic acid of type IV collagenolysis and invasion through reconsituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 49: 1698-1706, 1989.
27. Gum R, Wang H, Lengyel E, Juarez J and Boyd D: Regulation of 92 kDa type IV collagenase expression by the jun amino terminal kinase and the extracellular signal regulated kinase dependent signaling cascades. Oncogene 14: 1481-1493, 1997.
28. Oikarinen A and Salo S: Effects of retinoids on type IV collagenolytic activity in melanoma cells. Acta Derm Venereol 66: 346-348, 1986.
29. Miyamoto S, Akiyama SK and Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267: 883-885, 1995.
30. Hu L, Crowe DL, Rheinwaid JG, Chambon P and Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma lines. Cancer Res 51: 3972-3981, 1991.
31. Zhang XK, Liu Y, Lee MO and Pfahl M: A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 54: 5663-5669, 1994.
32. Kim YH, Dohi DF, Han GR, Zou CP, Oridate N, Walsh GL, Nesbitt JC, Xu XC, Hong WK, Lotan R and Kurie JM: Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res 55: 5603-5610, 1995.
33. May M, Mengus G, Lavigne AC, Chambon P and Davidson I: Human TAFII28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J 15: 3093-3104, 1996.
34. McInerney EM, Tsai MJ, O'Malley BW and Katzenellenbogen BS: Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA 93: 10069-10073, 1996.
35. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M and Evans RM: Role of CBP/p300 in nuclear receptor signaling. Nature 383: 99-103, 1996.
36. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK and Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414, 1996.
37. Smith CL, Onate SA, Tsai MJ and O'Malley BW: CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor dependent transcription. Proc Natl Acad Sci USA 93: 8884-8888, 1996.
38. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG and Glass CK: Polarity specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451-454, 1995.
39. Chen JD, Umesono K and Evans RM: SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93: 7567-7571, 1996.
40. Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM and Samuels HH: Functional evidence for ligand dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14: 5756-5765, 1994.
41. Pendas AM, Knauper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G and Lopez-Otin C: Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal localization, and tissue distribution. J Biol Chem 272: 4281-4286, 1997.